FIGURE 1 5 Interactions between smoking cessation medications and antituberculous drugs In the past few years, numerous studies have investigated the association between smoking and TB severity suggesting that the former has a negative impact on patients outcome, resulting in delayed culture conversion, treatment extension, and increasing risk of recurrence after pharmacotherapies completion (Slama et al., 2007
Table 1 Methodological quality assessment of the studies included in the systematic review Table 2 Description of the studies selected about EC use risk and protective factors, and motives for use In Figure 2, most studies are cross-sectional 47,50-53,55-58,64,66,67,70,71,75,78,79,96 , followed by longitudinal studies 54,61,62,68,74,76,77,80
Unlock a new level of smoking satisfaction with Elements Pink Rolling Papers
National Quitline (Me Mutu) service was launched in 1999